Applied Nutrition has announced plans to launch more products tailored for customers using weight loss drugs, following a surge in demand over the past year. The health and wellness brand noted a sharp increase in Britons using GLP-1 treatments such as Mounjaro and Wegovy, creating a business opportunity to cater specifically to these consumers.
The London-listed company, based in Liverpool, has already entered this market by selling GLP-1-friendly high-protein ready meals since late last year. Bosses confirmed that new products will be introduced later this year to further target this growing customer base.
Thomas Ryder, founder and chief executive, said the firm sees the GLP-1 user as a growing customer segment. He explained that these individuals often require supplements and smaller portions, presenting a catalyst for the health and wellness space. Ryder added that the company has seen growth by targeting new customer opportunities and expanding into UK retail stores.
Last month, Applied Nutrition reported stronger sales and profits for the six months to January 31, with pre-tax profits jumping 77.1% to £20.9 million and sales rising 56.5% to £74.5 million. However, the company cautioned that sales volumes in the Middle East are expected to be impacted by regional conflict.
